BKV

BKV Corporation

65
Fundamentals87/ 100
Valuation51/ 100
Upside potential63/ 100
Risk potential23/ 100

BKV's fundamentals are strong: revenue about doubled and its operating margin rose 21 points to 29%. At 8.7x earnings, it's trading in line with its usual 9.2x. Analysts expect that strong growth to continue.

BKV Fundamentals

MetricStatus
Healthy
Strong
Stable
Stable

BKV's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.

BKV PE Valuation

CHEAPFAIREXPENSIVE21x42x63x85x
CHEAPFAIREXPENSIVE21x42x63x85x
LevelPEPriceVs current
Cheap7.7x$17.11-11%
Current8.7x$19.27—
Fair9.1x$20.09+4.2%
Forward12x$19.27—
Expensive71x$157+715%

Historical ranges are pointers, not guarantees.

BKV's PE is in its fair range at 8.7x. On analysts' estimates for next year's earnings, today's price would be 12x.

BKV Forward outlook

MetricOutlook
Strongly deteriorating
Strong growth
Strong growth
Weakening
Limited
High

Analysts expect strong earnings and revenue growth for BKV, but weaker profitability.

BKV Risk to reward

ScenarioChangePrice
Upside+39%$26.88
Downside-23%$14.75

Calculated from the latest close: $19.27 on Nov 12.

BKV's one-year upside scenario is somewhat larger than its downside: +39% against −23%.

BKV Earnings Per Share

Q4 2023: $1.39Q1 2024: $-0.21Q2 2024: $-0.50Q3 2024: $-0.54Q4 2024: $-1.80Q1 2025: $-2.27Q2 2025: $-0.33Q3 2025: $0.39Q4 2025: $2.05Q1 2026: $3.40Q2 2026: $2.84Q3 2026: $2.21Forward: $1.66
Q4 2023: $1.39Q1 2024: $-0.21Q2 2024: $-0.50Q3 2024: $-0.54Q4 2024: $-1.80Q1 2025: $-2.27Q2 2025: $-0.33Q3 2025: $0.39Q4 2025: $2.05Q1 2026: $3.40Q2 2026: $2.84Q3 2026: $2.21Forward: $1.66
QuarterTTM EPSYoY
Forward$1.66-25%
Q3 2026$2.21+467%
Q2 2026$2.84+$3.17
Q1 2026$3.40+$5.67
Q4 2025$2.05+$3.85
Q3 2025$0.39+$0.93
Q2 2025-$0.33+$0.17
Q1 2025-$2.27-$2.06
Q4 2024-$1.80-229%

BKV's earnings per share have fallen from their peak: $2.21 over the past year, against $8.26 in early 2023.

BKV Quarterly Revenue

Q4 2023: $188MQ1 2024: $155MQ2 2024: $138MQ3 2024: $138MQ4 2024: $174MQ1 2025: $231MQ2 2025: $207MQ3 2025: $200MQ4 2025: $505MQ1 2026: $377MQ2 2026: $322MQ3 2026: $390M
Q4 2023: $188MQ1 2024: $155MQ2 2024: $138MQ3 2024: $138MQ4 2024: $174MQ1 2025: $231MQ2 2025: $207MQ3 2025: $200MQ4 2025: $505MQ1 2026: $377MQ2 2026: $322MQ3 2026: $390M
QuarterRevenueYoY
Q3 2026$390.3M+95%
Q2 2026$322.5M+56%
Q1 2026$376.5M+63%
Q4 2025$504.8M+190%
Q3 2025$199.8M+45%
Q2 2025$207.1M+51%
Q1 2025$231M+49%
Q4 2024$174.3M-7.2%

BKV's revenue is recovering but still below its 2021 peak: $390M last quarter, up 95% from the same quarter a year ago.

BKV Free Cash Flow

Q4 2023: −$19MQ1 2024: −$610,000Q2 2024: −$21MQ3 2024: --Q4 2024: $44MQ1 2025: $23MQ2 2025: --Q3 2025: −$127MQ4 2025: $11MQ1 2026: −$35MQ2 2026: $23MQ3 2026: $83M
Q4 2023: −$19MQ1 2024: −$610,000Q2 2024: −$21MQ3 2024: --Q4 2024: $44MQ1 2025: $23MQ2 2025: --Q3 2025: −$127MQ4 2025: $11MQ1 2026: −$35MQ2 2026: $23MQ3 2026: $83M
QuarterFree cash flowYoY
Q3 2026$83M+$209.9M
Q1 2026-$34.5M-253%
Q4 2025$10.9M-75%
Q1 2025$22.6M+$23.2M
Q4 2024$43.8M+$62.8M
Q2 2024-$21.2M-180%
Q1 2024-$610K+$75.3M
Q4 2023-$19M-$13.8M

BKV's free cash flow has turned positive after three years mostly in the red: $82M over the past year.

BKV Total Shares

Q4 2023: 84MQ1 2024: 84MQ2 2024: 84MQ3 2024: 71MQ4 2024: 71MQ1 2025: 85MQ2 2025: 85MQ3 2025: 85MQ4 2025: 87MQ1 2026: 102MQ2 2026: 110MQ3 2026: 109M
Q4 2023: 84MQ1 2024: 84MQ2 2024: 84MQ3 2024: 71MQ4 2024: 71MQ1 2025: 85MQ2 2025: 85MQ3 2025: 85MQ4 2025: 87MQ1 2026: 102MQ2 2026: 110MQ3 2026: 109M
PeriodChange %Net change
Quarterly-0.4%-390K shares
1 year+29%+24.4M shares
3 years+30%+25.3M shares
5 years+30%+25.3M shares

BKV has 109M diluted shares, up 29% from a year ago.

BKV Net Leverage

Q4 2023: 1.2xQ1 2024: 1.8xQ2 2024: 1.6xQ3 2025: 1.8xQ4 2025: 1.8xQ1 2026: 1.4xQ2 2026: 1.6xQ3 2026: 2.0x
Q4 2023: 1.2xQ1 2024: 1.8xQ2 2024: 1.6xQ3 2025: 1.8xQ4 2025: 1.8xQ1 2026: 1.4xQ2 2026: 1.6xQ3 2026: 2.0x
QuarterNet LeverageStatus
Q3 20262.0xHealthy
Q2 20261.6xHealthy
Q1 20261.4xHealthy
Q4 20251.8xHealthy
Q3 20251.8xHealthy
Q2 20241.6xHealthy
Q1 20241.8xHealthy
Q4 20231.2xHealthy

BKV's net debt is about 2.0 years of its operating earnings (EBITDA), up from 1.8 years a year ago.

BKV Weekly Momentum

MetricValueStatus
RSI38.6Neutral
Stochastic10.4Oversold

BKV's weekly RSI is 39 (neutral) and its Stochastic is 10 (oversold).

BKV PE vs Energy Sector

MetricBKVSector medianRelative
PE8.7x13x34% below
PE %463511 pts above

BKV is trading at 8.7x earnings, a 34% discount to the Energy sector's median of 13x.

BKV Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$21.18.6% below
20 week MA$23.518% below
50 week MA$26.427% below
100 week MA$24.321% below

BKV is in a downtrend: it's below all four of its weekly moving averages, and 21% below its 100-week average.

BKV Yearly ROI

YearStart priceEnd priceROI
2024$18.1$22.5+25%
2025$22.5$27.3+21%
2026 YTD$27.3$19.3-29%

BKV has finished every year since 2024 higher, and it's down 29% so far in 2026.

Give your agent the market.

Get API key